Introduction to Mounjaro
Mounjaro is a pioneering weight management solution that became available in the UK, including the Isle of Man, in 2024. This medication offers a novel approach to support individuals in their weight loss journey, to be used alongside a healthy diet and regular exercise.
What is Mounjaro?
Mounjaro is a prescription medication intended to aid weight loss in adults who are obese or overweight and have weight-related health conditions. It is designed to work by affecting hormones that regulate hunger and insulin, thereby contributing to weight management.
How Mounjaro Functions
Mounjaro influences the body’s natural mechanisms for regulating appetite and sugar levels. It reduces hunger, enhances insulin effectiveness, and delays the absorption of food, supporting overall weight management efforts.
Who is Eligible for Mounjaro?
- Adults with a Body Mass Index (BMI) of 30 kg/m² or higher.
- Adults with a BMI of at least 27 kg/m² who also have conditions linked to their weight, such as type 2 diabetes, high blood pressure, or abnormal cholesterol levels.
Administration Guidelines and Dosage
Mounjaro is administered through subcutaneous injections. A healthcare provider will determine the specific dosage and frequency, tailored to the individual’s health status and weight loss objectives.At Tracey Bell we will assess the suitability of the drug for you.
Key Benefits
- Substantial weight loss: Clinical studies have demonstrated that Mounjaro can significantly reduce weight.
- Metabolic health improvement: It may also positively impact blood sugar levels and markers of cardiovascular health.
- User-friendly: Mounjaro’s once-weekly injection schedule is designed to integrate seamlessly into daily routines.
Potential Side Effects
Common side effects associated with Mounjaro include nausea, diarrhoea, constipation, and reactions at the injection site. These effects are typically mild to moderate and tend to diminish over time. Discussing with your healthcare provider for a comprehensive list of side effects is important.
Important Safety Information
- Mounjaro is not appropriate for all individuals. It’s crucial to discuss your full medical history with your healthcare provider.
- Mounjaro is not recommended for use during pregnancy or breastfeeding without medical consultation.
- Adhering to the prescribed dietary and exercise recommendations is essential for the best outcomes with Mounjaro.
Accessing Mounjaro
A prescription is necessary for Mounjaro, available through weight management programs in the UK and the Isle of Man. Consultation with a healthcare provider is required to assess if Mounjaro is a suitable option.At Tracey Bell we provide this treatment.
Contraindications
- Known allergies to Mounjaro or any of its components.
- History of severe gastrointestinal diseases or disorders.
- Individuals with a history of pancreatitis should use Mounjaro with caution.
Expected Weight Loss and Complications
Patients can anticipate a significant reduction in body weight, with clinical trials reporting an average weight loss of up to 15-20% of body weight over 12 months. However, as with any medication, there is a possibility of complications, including gastrointestinal issues and potential effects on pancreas and thyroid health.
Non-Responders
It’s noted that a small percentage of individuals may not respond to Mounjaro as expected. Approximately 10-15% of users might experience less significant weight loss. Ongoing consultation with a healthcare provider is recommended to adjust treatment plans as necessary.
Relevant PDF Downloads
Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program
Package leaflet: Information for the patient
Summary of product characteristics
Your guide to Mounjaro (tirzepatide) and the KwikPen device